Jeremy Boussier

8PUBLICATIONS

54CO-AUTHORS

AutoimmunityWireless communication systems and technologies (incl. microwave and millimetrewave)Molecular targetsCardiology (incl. cardiovascular diseases)Biologically active molecules

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (8)

Sort by Publication Date:

|Jan 30, 2024

VEXAS syndrome is characterized by inflammasome activation and monocyte dysregulation.

|Jul 31, 2023

Anesthesia Teleconsultation: Quality, Medicoeconomic Interest, and Patient Satisfaction of Preoperative Assessment-A Prospective Observational Study.

Cyril Quemeneur, Frédéric Le Saché, Corentyn Ayrault

|Aug 19, 2021

Immune checkpoint inhibitors increase T cell immunity during SARS-CoV-2 infection.

Nader Yatim, Jeremy Boussier, Pauline Tetu

|Jul 17, 2021

Platelet activation in critically ill COVID-19 patients.

Nader Yatim, Jeremy Boussier, Richard Chocron

|Feb 08, 2021

Defective viral genomes from chikungunya virus are broad-spectrum antivirals and prevent virus dissemination in mosquitoes.

Laura I Levi, Veronica V Rezelj, Annabelle Henrion-Lacritick

|Nov 12, 2020

Chikungunya virus superinfection exclusion is mediated by a block in viral replication and does not rely on non-structural protein 2.

Jeremy Boussier, Laura Levi, James Weger-Lucarelli

Pageof 2

Frequent Collaborators

Darragh Duffy

Nader Yatim

Laura I Levi

Veronica V Rezelj

Paul Breillat

Bruno Charbit

James Weger-Lucarelli

2 joint publications

Frédéric Rieux-Laucat

2 joint publications

Pierre-Louis Tharaux

2 joint publications

Nikaïa Smith

Frequent Collaborators

Darragh Duffy

Nader Yatim

Laura I Levi

Veronica V Rezelj